Patents by Inventor Irina Ushach

Irina Ushach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IDENTIFICATION OF A NOVEL B CELL CYTOKINE
    Publication number: 20200087368
    Abstract: Compositions and methods involving IL40, a novel cytokine produced by activated B cells, are provided. The compositions include: a) anti-IL40 antibodies, IL40 peptides and IL40 proteins; b) nucleic acids encoding IL40 gene and cDNA sequences; and c) pharmaceutical compositions thereof. The methods include treatments, diagnostics and isolation technologies.
    Type: Application
    Filed: November 21, 2019
    Publication date: March 19, 2020
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Albert Zlotnik, Peter Hevezi, Van Phi Luu, Amanda M. Burkhardt, Irina Ushach
  • USES OF IL-41
    Publication number: 20190262425
    Abstract: Methods of using Metrnl/IL-41 to identify inflammation, inflammatory and autoimmune diseases, infection and cancer in a subject are provided. The methods include determining the serum or plasma levels of Metrnl/IL-41 in the subject. Methods of modulating a condition selected from cytokine release syndrome, systemic immune response syndrome, cytokine storm, or a combination thereof, using Metrnl/IL-41 or antibodies against Metrnl/I-41 are also provided.
    Type: Application
    Filed: June 10, 2017
    Publication date: August 29, 2019
    Applicant: The Regents of the University of California
    Inventors: Albert ZLOTNIK, Irina USHACH
  • IDENTIFICATION OF A NOVEL B CELL CYTOKINE
    Publication number: 20160297860
    Abstract: Compositions and methods involving IL40, a novel cytokine produced by activated B cells, are provided. The compositions include: a) anti-IL40 antibodies, IL40 peptides and IL40 proteins; b) nucleic acids encoding IL40 gene and cDNA sequences; and c) pharmaceutical compositions thereof. The methods include treatments, diagnostics and isolation technologies.
    Type: Application
    Filed: November 20, 2014
    Publication date: October 13, 2016
    Applicant: The Regents of the University of California
    Inventors: Albert Zlotnik, Peter Hevezi, Van Phi Luu, Amanda M. Burkhardt, Irina Ushach